KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Humana (HUM) Short-Term Debt issuances (2016 - 2025)

Humana has reported Short-Term Debt issuances over the past 17 years, most recently at -$2.0 million for Q4 2025.

  • Quarterly results put Short-Term Debt issuances at -$2.0 million for Q4 2025, up 99.78% from a year ago — trailing twelve months through Dec 2025 was -$97.0 million (up 89.31% YoY), and the annual figure for FY2025 was -$97.0 million, up 89.31%.
  • Short-Term Debt issuances for Q4 2025 was -$2.0 million at Humana, up from -$90.0 million in the prior quarter.
  • Over the last five years, Short-Term Debt issuances for HUM hit a ceiling of $1.5 billion in Q3 2023 and a floor of -$910.0 million in Q4 2024.
  • Median Short-Term Debt issuances over the past 5 years was -$500000.0 (2024), compared with a mean of $34.5 million.
  • Biggest five-year swings in Short-Term Debt issuances: skyrocketed 1300.0% in 2023 and later crashed 9100.0% in 2025.
  • Humana's Short-Term Debt issuances stood at $432.0 million in 2021, then plummeted by 166.44% to -$287.0 million in 2022, then skyrocketed by 134.84% to $100.0 million in 2023, then plummeted by 1010.0% to -$910.0 million in 2024, then surged by 99.78% to -$2.0 million in 2025.
  • The last three reported values for Short-Term Debt issuances were -$2.0 million (Q4 2025), -$90.0 million (Q3 2025), and $28.0 million (Q2 2025) per Business Quant data.